var data={"title":"Secretin","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Secretin</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/secretin/contributors\" class=\"contributor contributor_credentials\">Rodger A Liddle, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/secretin/contributors\" class=\"contributor contributor_credentials\">J Thomas Lamont, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/secretin/contributors\" class=\"contributor contributor_credentials\">Shilpa Grover, MD, MPH, AGAF</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/secretin/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;May 16, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The field of endocrinology and the study of &quot;hormones&quot; began at the turn of the 20<sup>th</sup> century when Bayliss and Starling described a chemical substance in intestinal extracts that, when injected intravenously, stimulated pancreatic secretion [<a href=\"https://www.uptodate.com/contents/secretin/abstract/1\" class=\"abstract_t\">1</a>]. They named this substance <a href=\"topic.htm?path=secretin-drug-information\" class=\"drug drug_general\">secretin</a> because it caused the pancreas to secrete fluid when acid was present in the gut. This discovery led to a search for other chemical substances that when released from one tissue could excite or stimulate organ function in a different location. The Greek word &quot;hormone,&quot; meaning &quot;arise to activity,&quot; was used to designate these chemical messengers. It is now known that secretin stimulates pancreatic fluid and bicarbonate secretion leading to neutralization of acidic chyme in the intestine. Secretin also inhibits gastric acid release and intestinal motility.</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">MOLECULAR FORMS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Despite knowledge of physiological activity, it took more than 50 years for the chemical nature of the hormone <a href=\"topic.htm?path=secretin-drug-information\" class=\"drug drug_general\">secretin</a> to be identified. The amino acid sequence was not determined until the 1960s [<a href=\"https://www.uptodate.com/contents/secretin/abstract/2\" class=\"abstract_t\">2</a>]. Human secretin is a 27 amino-acid peptide, with a molecular weight of 3055 D. Its sequence is conserved across many mammalian species (<a href=\"image.htm?imageKey=GAST%2F58228\" class=\"graphic graphic_figure graphicRef58228 \">figure 1</a>).</p><p>Similar to other gastrointestinal peptides, <a href=\"topic.htm?path=secretin-drug-information\" class=\"drug drug_general\">secretin</a> is amidated at the C-terminus. It is the founding member of the <span class=\"nowrap\">secretin/glucagon/vasoactive</span> intestinal polypeptide family of gastrointestinal hormones. The gene structure of preprosecretin contains an N-terminal signal peptide, a short peptide sequence, secretin, and a C-terminal extension peptide [<a href=\"https://www.uptodate.com/contents/secretin/abstract/3\" class=\"abstract_t\">3</a>]. The gene encoding secretin is selectively expressed in specialized enteroendocrine cells of the small intestine, called S cells. The details of secretin gene transcriptional control have been studied in secretin-producing islet cells [<a href=\"https://www.uptodate.com/contents/secretin/abstract/4\" class=\"abstract_t\">4</a>].</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">TISSUE DISTRIBUTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Immunocytochemistry has demonstrated that <a href=\"topic.htm?path=secretin-drug-information\" class=\"drug drug_general\">secretin</a>-producing cells are found along the small intestine (<a href=\"image.htm?imageKey=GAST%2F76730\" class=\"graphic graphic_figure graphicRef76730 \">figure 2</a>) [<a href=\"https://www.uptodate.com/contents/secretin/abstract/5\" class=\"abstract_t\">5</a>]. Other sites shown to produce secretin mRNA include the hypothalamus, cortex, cerebellum, and brainstem [<a href=\"https://www.uptodate.com/contents/secretin/abstract/3,6\" class=\"abstract_t\">3,6</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">RECEPTORS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The <a href=\"topic.htm?path=secretin-drug-information\" class=\"drug drug_general\">secretin</a> receptor is a member of the family of G protein-coupled receptors (GPCRs), within which the <span class=\"nowrap\">secretin/glucagon</span> family is structurally unique. This group consists of receptors for secretin, glucagon, calcitonin, parathyroid hormone, pituitary adenylyl cyclase-activating peptide (PACAP), vasoactive intestinal polypeptide, and others. These receptors lack structural signature sequences present in the <span class=\"nowrap\">rhodopsin/beta-adrenergic</span> receptor family (such as a DRY motif &mdash; Asp-Arg-Tyr &mdash; at the end of the third transmembrane spanning domain), which appear to be important in receptor coupling to G proteins. Secretin binds to its specific heptahelical membrane receptor and activates the heterotrimeric G protein, Gs, leading to elevation of cellular cAMP levels. This second messenger begins the signaling cascade that initiates appropriate cell physiological responses. (See <a href=\"topic.htm?path=peptide-hormone-signal-transduction-and-regulation\" class=\"medical medical_review\">&quot;Peptide hormone signal transduction and regulation&quot;</a>.)</p><p>The mechanisms for <a href=\"topic.htm?path=secretin-drug-information\" class=\"drug drug_general\">secretin</a> receptor signal termination involve receptor phosphorylation [<a href=\"https://www.uptodate.com/contents/secretin/abstract/7\" class=\"abstract_t\">7</a>], mediated by GPCR kinases [<a href=\"https://www.uptodate.com/contents/secretin/abstract/8\" class=\"abstract_t\">8</a>]. The mechanism for secretin receptor internalization is distinct from that used by prototypical Class I GPCRs [<a href=\"https://www.uptodate.com/contents/secretin/abstract/9\" class=\"abstract_t\">9</a>]. The specific mechanism for receptor internalization suggests that novel proteins may be involved in its regulation.</p><p><a href=\"topic.htm?path=secretin-drug-information\" class=\"drug drug_general\">Secretin</a> receptors are abundant on duct and acinar cells of the pancreas, where they mediate secretin-stimulated fluid and bicarbonate secretion and may potentiate cholecystokinin and acetylcholine-stimulated enzyme secretion. Secretin receptors are also present in brain cells, sensory neurons in the vagus nerve, and endocrine and other cells of the gastrointestinal tract. It is possible the secretin and cholecystokinin receptors on vagal sensory neurons synergistically enhance postprandial pancreatic enzyme secretion [<a href=\"https://www.uptodate.com/contents/secretin/abstract/10\" class=\"abstract_t\">10</a>].</p><p><a href=\"topic.htm?path=secretin-drug-information\" class=\"drug drug_general\">Secretin</a> receptors are also found on some tumors of the gastrointestinal tract. Alternative splicing of secreting receptor pre-mRNA in such tumors may be biologically important for understanding the function of the receptor and in developing potential chemotherapeutic targets [<a href=\"https://www.uptodate.com/contents/secretin/abstract/11\" class=\"abstract_t\">11</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h1\">SECRETIN RELEASE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The major physiological actions of <a href=\"topic.htm?path=secretin-drug-information\" class=\"drug drug_general\">secretin</a> are stimulation of pancreatic fluid and bicarbonate secretion. Bicarbonate, upon reaching the duodenum, neutralizes gastric acid and raises the duodenal pH, thereby &quot;turning off&quot; secretin release via a negative feedback mechanism [<a href=\"https://www.uptodate.com/contents/secretin/abstract/12\" class=\"abstract_t\">12</a>]. It has been suggested that acid-stimulated secretin release is regulated by an endogenous intestinal secretin-releasing factor (SRF) (<a href=\"image.htm?imageKey=GAST%2F74092\" class=\"graphic graphic_figure graphicRef74092 \">figure 3</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/secretin/abstract/13\" class=\"abstract_t\">13</a>]. This peptide stimulates secretin until the flow of pancreatic proteases is sufficient to degrade the releasing factor and terminate secretin release. Confirmation of this negative feedback pathway awaits identification of the putative SRF.</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h1\">PHYSIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although the primary action of <a href=\"topic.htm?path=secretin-drug-information\" class=\"drug drug_general\">secretin</a> is to produce pancreatic fluid and bicarbonate secretion [<a href=\"https://www.uptodate.com/contents/secretin/abstract/14\" class=\"abstract_t\">14</a>], it is also an enterogastrone (a substance that is released by ingested fat and inhibits gastric acid secretion). In physiological concentrations, secretin inhibits gastric acid release, gastric motility, and gastrin release [<a href=\"https://www.uptodate.com/contents/secretin/abstract/15\" class=\"abstract_t\">15</a>]. When studied using pharmacologic doses, secretin also increases bile flow, gastrointestinal motility, and lower esophageal sphincter pressure, and stimulates insulin release following the ingestion of glucose [<a href=\"https://www.uptodate.com/contents/secretin/abstract/16-19\" class=\"abstract_t\">16-19</a>]. </p><p>Many studies suggest that <a href=\"topic.htm?path=secretin-drug-information\" class=\"drug drug_general\">secretin</a> can promote growth of the pancreas [<a href=\"https://www.uptodate.com/contents/secretin/abstract/20\" class=\"abstract_t\">20</a>]. This latter finding has raised speculation that secretin may contribute to pancreatic cancer [<a href=\"https://www.uptodate.com/contents/secretin/abstract/21\" class=\"abstract_t\">21</a>]. However, direct evidence for secretin in the pathogenesis of pancreatic cancer is currently lacking. Interestingly, targeted ablation (knockout) of secretin-producing cells in transgenic mice resulted in an animal devoid of many enteroendocrine cells, suggesting that secretin expression may be necessary at an early step in the development of gut endocrine cells [<a href=\"https://www.uptodate.com/contents/secretin/abstract/22\" class=\"abstract_t\">22</a>].</p><p>Like several other gut peptides, <a href=\"topic.htm?path=secretin-drug-information\" class=\"drug drug_general\">secretin</a> has anorectic properties when administered centrally or peripherally [<a href=\"https://www.uptodate.com/contents/secretin/abstract/23\" class=\"abstract_t\">23</a>]. The central effects of secretin on satiety are mediated by the melanocortin system. The satiety-inducing effects of peripherally administered secretin are blocked by vagotomy or ablating sensory nerves with <a href=\"topic.htm?path=capsaicin-drug-information\" class=\"drug drug_general\">capsaicin</a>, indicating that secretin signals through the sensory fibers of the vagus nerve [<a href=\"https://www.uptodate.com/contents/secretin/abstract/24\" class=\"abstract_t\">24</a>]. Although the satiety effects of secretin are relatively weak compared with other gut peptides such as cholecystokinin or peptide YY, its action on the vagus nerve highlights the importance of this neural pathway in regulating signals from the gut to the brain.</p><p>The physiological role of <a href=\"topic.htm?path=secretin-drug-information\" class=\"drug drug_general\">secretin</a> in the brain is incompletely understood, although it may act as a neuropeptide. Impaired synaptic plasticity and antisocial behavior has been observed in secretin-receptor-deficient mice [<a href=\"https://www.uptodate.com/contents/secretin/abstract/25\" class=\"abstract_t\">25</a>]. During development, secretin has neurotrophic effects on serotoninergic mesencephalic neurons, and these effects are lost in neurodegenerative diseases [<a href=\"https://www.uptodate.com/contents/secretin/abstract/26\" class=\"abstract_t\">26</a>].</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h1\">CLINICAL USES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most common clinical application of <a href=\"topic.htm?path=secretin-drug-information\" class=\"drug drug_general\">secretin</a> is in the diagnosis of gastrin-secreting tumors. Under normal conditions, secretin administration inhibits gastrin release (see <a href=\"#H6\" class=\"local\">'Physiology'</a> above). However, in gastrinomas, injection of secretin causes a paradoxical increase in gastrin release. This pathophysiological phenomenon is the basis for the secretin stimulation test. This test is a safe, effective, and reliable method for determining the presence of a gastrin-producing tumor (<a href=\"image.htm?imageKey=GAST%2F64937\" class=\"graphic graphic_table graphicRef64937 \">table 1</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/secretin/abstract/27,28\" class=\"abstract_t\">27,28</a>]. (See <a href=\"topic.htm?path=zollinger-ellison-syndrome-gastrinoma-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Zollinger-Ellison syndrome (gastrinoma): Clinical manifestations and diagnosis&quot;</a>.)</p><p>Due to its effect on pancreatic exocrine secretion, <a href=\"topic.htm?path=secretin-drug-information\" class=\"drug drug_general\">secretin</a> has been used clinically to diagnose pancreatic insufficiency [<a href=\"https://www.uptodate.com/contents/secretin/abstract/29,30\" class=\"abstract_t\">29,30</a>] (see <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-malabsorption\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of malabsorption&quot;</a>). Acute administration of secretin causes temporary dilation of pancreatic ducts by increasing pancreatic secretions. This pharmacologic effect is the basis for administration of secretin during endoscopic retrograde cholangiopancreatography to aid in ductal cannulation (primarily the minor duct) (see <a href=\"topic.htm?path=pancreas-divisum-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Pancreas divisum: Clinical manifestations and diagnosis&quot;</a>). In addition, secretin has been used in magnetic resonance imaging of the pancreas during functional testing to evaluate pancreatic secretion and ductal obstruction [<a href=\"https://www.uptodate.com/contents/secretin/abstract/31,32\" class=\"abstract_t\">31,32</a>]. Secretin-enhanced magnetic resonance cholangiopancreatography is particularly useful to detect and diagnose congenital, inflammatory, and neoplastic conditions of the pancreas and may be more useful than standard magnetic resonance imaging to evaluate subtle changes in chronic pancreatitis [<a href=\"https://www.uptodate.com/contents/secretin/abstract/33,34\" class=\"abstract_t\">33,34</a>]. In addition, secretin administration appears to accentuate regions of pancreatic vascular hypoperfusion [<a href=\"https://www.uptodate.com/contents/secretin/abstract/35\" class=\"abstract_t\">35</a>].</p><p>Anecdotal reports suggest that <a href=\"topic.htm?path=secretin-drug-information\" class=\"drug drug_general\">secretin</a> administration might be an effective treatment for autism spectrum disorders. However, these early reports have not been validated in randomized controlled trials and secretin is not recommended for treatment of autism [<a href=\"https://www.uptodate.com/contents/secretin/abstract/36\" class=\"abstract_t\">36</a>].</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=secretin-drug-information\" class=\"drug drug_general\">Secretin</a> is a 27 amino-acid peptide produced by cells in the small intestine, hypothalamus, cortex, cerebellum, and brainstem. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above and <a href=\"#H2\" class=\"local\">'Molecular forms'</a> above.).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=secretin-drug-information\" class=\"drug drug_general\">Secretin</a> receptors are abundant on duct and acinar cells of the pancreas, where they mediate secretin-stimulated fluid and bicarbonate secretion leading to neutralization of acidic chyme in the intestine and may potentiate cholecystokinin and acetylcholine-stimulated enzyme secretion. (See <a href=\"#H3\" class=\"local\">'Tissue distribution'</a> above and <a href=\"#H4\" class=\"local\">'Receptors'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The most common clinical application of <a href=\"topic.htm?path=secretin-drug-information\" class=\"drug drug_general\">secretin</a> is in the diagnosis of gastrin-secreting tumors. Under normal conditions, secretin administration inhibits gastrin release. However, in gastrinomas, injection of secretin causes a paradoxical increase in gastrin release. This pathophysiological phenomenon is the basis for the secretin stimulation test. (See <a href=\"#H6\" class=\"local\">'Physiology'</a> above and <a href=\"#H7\" class=\"local\">'Clinical uses'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/1\" class=\"nounderline abstract_t\">Bayliss WM, Starling EH. The mechanism of pancreatic secretion. J Physiol 1902; 28:325.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/2\" class=\"nounderline abstract_t\">Mutt V, Jorpes JE, Magnusson S. Structure of porcine secretin. The amino acid sequence. Eur J Biochem 1970; 15:513.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/3\" class=\"nounderline abstract_t\">Kopin AS, Wheeler MB, Leiter AB. Secretin: structure of the precursor and tissue distribution of the mRNA. Proc Natl Acad Sci U S A 1990; 87:2299.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/4\" class=\"nounderline abstract_t\">Nishitani J, Rindi G, Lopez MJ, et al. Transcriptional regulation of secretin gene expression. J Clin Gastroenterol 1995; 21 Suppl 1:S50.</a></li><li class=\"breakAll\">Leiter AB, Chey WY, Kopin AS. Secretin, 1st ed, Raven Press, New York 1994.</li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/6\" class=\"nounderline abstract_t\">Lee SM, Yung WH, Chen L, Chow BK. Expression and spatial distribution of secretin and secretin receptor in human cerebellum. Neuroreport 2005; 16:219.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/7\" class=\"nounderline abstract_t\">Ozcelebi F, Holtmann MH, Rentsch RU, et al. Agonist-stimulated phosphorylation of the carboxyl-terminal tail of the secretin receptor. Mol Pharmacol 1995; 48:818.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/8\" class=\"nounderline abstract_t\">Shetzline MA, Premont RT, Walker JK, et al. A role for receptor kinases in the regulation of class II G protein-coupled receptors. Phosphorylation and desensitization of the secretin receptor. J Biol Chem 1998; 273:6756.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/9\" class=\"nounderline abstract_t\">Walker JK, Premont RT, Barak LS, et al. Properties of secretin receptor internalization differ from those of the beta(2)-adrenergic receptor. J Biol Chem 1999; 274:31515.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/10\" class=\"nounderline abstract_t\">Li Y. Sensory signal transduction in the vagal primary afferent neurons. Curr Med Chem 2007; 14:2554.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/11\" class=\"nounderline abstract_t\">K&ouml;rner M, Miller LJ. Alternative splicing of pre-mRNA in cancer: focus on G protein-coupled peptide hormone receptors. Am J Pathol 2009; 175:461.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/12\" class=\"nounderline abstract_t\">Schaffalitzky de Muckadell OB, Fahrenkrug J. Secretion pattern of secretin in man: regulation by gastric acid. Gut 1978; 19:812.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/13\" class=\"nounderline abstract_t\">Li P, Lee KY, Chang TM, Chey WY. Mechanism of acid-induced release of secretin in rats. Presence of a secretin-releasing peptide. J Clin Invest 1990; 86:1474.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/14\" class=\"nounderline abstract_t\">You CH, Rominger JM, Chey WY. Effects of atropine on the action and release of secretin in humans. Am J Physiol 1982; 242:G608.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/15\" class=\"nounderline abstract_t\">You CH, Chey WY. Secretin is an enterogastrone in humans. Dig Dis Sci 1987; 32:466.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/16\" class=\"nounderline abstract_t\">Boyer JL, Bloomer JR. Canalicular bile secretion in man. Studies utilizing the biliary clearance of (14C)mannitol. J Clin Invest 1974; 54:773.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/17\" class=\"nounderline abstract_t\">Dinoso VP Jr, Meshkinpour H, Lorber SH, et al. Motor responses of the sigmoid colon and rectum to exogenous cholecystokinin and secretin. Gastroenterology 1973; 65:438.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/18\" class=\"nounderline abstract_t\">Cohen S, Lipshutz W. Hormonal regulation of human lower esophageal sphincter competence: interaction of gastrin and secretin. J Clin Invest 1971; 50:449.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/19\" class=\"nounderline abstract_t\">Afroze S, Meng F, Jensen K, et al. The physiological roles of secretin and its receptor. Ann Transl Med 2013; 1:29.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/20\" class=\"nounderline abstract_t\">Solomon TE, Vanier M, Morisset J. Cell site and time course of DNA synthesis in pancreas after caerulein and secretin. Am J Physiol 1983; 245:G99.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/21\" class=\"nounderline abstract_t\">Talamini G. Duodenal acidity may increase the risk of pancreatic cancer in the course of chronic pancreatitis: an etiopathogenetic hypothesis. JOP 2005; 6:122.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/22\" class=\"nounderline abstract_t\">Rindi G, Ratineau C, Ronco A, et al. Targeted ablation of secretin-producing cells in transgenic mice reveals a common differentiation pathway with multiple enteroendocrine cell lineages in the small intestine. Development 1999; 126:4149.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/23\" class=\"nounderline abstract_t\">Cheng CY, Chu JY, Chow BK. Central and peripheral administration of secretin inhibits food intake in mice through the activation of the melanocortin system. Neuropsychopharmacology 2011; 36:459.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/24\" class=\"nounderline abstract_t\">Chu JY, Cheng CY, Sekar R, Chow BK. Vagal afferent mediates the anorectic effect of peripheral secretin. PLoS One 2013; 8:e64859.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/25\" class=\"nounderline abstract_t\">Nishijima I, Yamagata T, Spencer CM, et al. Secretin receptor-deficient mice exhibit impaired synaptic plasticity and social behavior. Hum Mol Genet 2006; 15:3241.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/26\" class=\"nounderline abstract_t\">Lossi L, Bottarelli L, Candusso ME, et al. Transient expression of secretin in serotoninergic neurons of mouse brain during development. Eur J Neurosci 2004; 20:3259.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/27\" class=\"nounderline abstract_t\">McGuigan JE, Wolfe MM. Secretin injection test in the diagnosis of gastrinoma. Gastroenterology 1980; 79:1324.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/28\" class=\"nounderline abstract_t\">Brady CE 3rd. Secretin provocation test in the diagnosis of Zollinger-Ellison syndrome. Am J Gastroenterol 1991; 86:129.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/29\" class=\"nounderline abstract_t\">Catalano MF, Lahoti S, Geenen JE, Hogan WJ. Prospective evaluation of endoscopic ultrasonography, endoscopic retrograde pancreatography, and secretin test in the diagnosis of chronic pancreatitis. Gastrointest Endosc 1998; 48:11.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/30\" class=\"nounderline abstract_t\">Raimondo M, Imoto M, DiMagno EP. Rapid endoscopic secretin stimulation test and discrimination of chronic pancreatitis and pancreatic cancer from disease controls. Clin Gastroenterol Hepatol 2003; 1:397.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/31\" class=\"nounderline abstract_t\">Khalid A, Peterson M, Slivka A. Secretin-stimulated magnetic resonance pancreaticogram to assess pancreatic duct outflow obstruction in evaluation of idiopathic acute recurrent pancreatitis: a pilot study. Dig Dis Sci 2003; 48:1475.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/32\" class=\"nounderline abstract_t\">Monill J, Pernas J, Clavero J, et al. Pancreatic duct after pancreatoduodenectomy: morphologic and functional evaluation with secretin-stimulated MR pancreatography. AJR Am J Roentgenol 2004; 183:1267.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/33\" class=\"nounderline abstract_t\">Akisik MF, Sandrasegaran K, Aisen AA, et al. Dynamic secretin-enhanced MR cholangiopancreatography. Radiographics 2006; 26:665.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/34\" class=\"nounderline abstract_t\">Balci NC, Alkaade S, Magas L, et al. Suspected chronic pancreatitis with normal MRCP: findings on MRI in correlation with secretin MRCP. J Magn Reson Imaging 2008; 27:125.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/35\" class=\"nounderline abstract_t\">Bali MA, Metens T, Denolin V, et al. Pancreatic perfusion: noninvasive quantitative assessment with dynamic contrast-enhanced MR imaging without and with secretin stimulation in healthy volunteers--initial results. Radiology 2008; 247:115.</a></li><li><a href=\"https://www.uptodate.com/contents/secretin/abstract/36\" class=\"nounderline abstract_t\">Williams K, Wray JA, Wheeler DM. Intravenous secretin for autism spectrum disorders (ASD). Cochrane Database Syst Rev 2012; :CD003495.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 2560 Version 9.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H8\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">MOLECULAR FORMS</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">TISSUE DISTRIBUTION</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">RECEPTORS</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">SECRETIN RELEASE</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">PHYSIOLOGY</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">CLINICAL USES</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"GAST/2560|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=GAST/58228\" class=\"graphic graphic_figure\">- Secretin amino acid sequence</a></li><li><a href=\"image.htm?imageKey=GAST/76730\" class=\"graphic graphic_figure\">- Secretin tissue distribution</a></li><li><a href=\"image.htm?imageKey=GAST/74092\" class=\"graphic graphic_figure\">- Secretin regulation</a></li></ul></li><li><div id=\"GAST/2560|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=GAST/64937\" class=\"graphic graphic_table\">- Secretin stimulation test</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-diagnosis-of-malabsorption\" class=\"medical medical_review\">Clinical features and diagnosis of malabsorption</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pancreas-divisum-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Pancreas divisum: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=peptide-hormone-signal-transduction-and-regulation\" class=\"medical medical_review\">Peptide hormone signal transduction and regulation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=zollinger-ellison-syndrome-gastrinoma-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Zollinger-Ellison syndrome (gastrinoma): Clinical manifestations and diagnosis</a></li></ul></div></div>","javascript":null}